Overview

Research Interests: Urologic/Genitourinary Pathology
Dr. Osunkoya's research interests are mainly in the field of Urologic/Genitourinary pathology. Prostate: Dr. Osunkoya and his collaborators have studied one of the largest series to date of mucinous prostate cancer, colon cancer with prostatic involvement, primary mucin-producing urothelial-type adenocarcinoma of prostate (mucinous adenocarcinoma of the prostatic urethra) and prostate cancer with aberrant p63 expression. They have also analyzed the expression of MUC-2, VEGF and ZEB-1 in prostate cancer, and have utilized multiplexed quantum dots in molecular mapping of tumor heterogeneity on tissue specimens of patients with prostate cancer. Kidney: Dr. Osunkoya and his collaborators have analyzed diagnostic biomarkers for renal cell carcinoma (RCC), based on a selection utilizing novel bioinformatics systems for microarray data analysis. They have also studied the utility of Claudin 7 and 8 in the distinction between renal oncocytoma and chromophobe RCC, and the expression of PAX-2 and CA-IX in RCC. In addition, they are one of the first groups to confirm the distinction between tubulocystic carcinoma and collecting duct carcinoma of the kidney at the molecular level, based on comparison of gene expression profiles. Urinary Bladder: Dr. Osunkoya and his collaborators were the first group to describe a unique subtype of bladder cancer (urothelial carcinoma with villoglandular differentiation). They have also analyzed one of the largest series to date of plasmacytoid urothelial carcinoma and smooth muscle neoplasms of the urinary bladder. Testis: Dr. Osunkoya and his collaborators have analyzed the significance of rete testis involvement by malignant germ cell tumors and/or germ cell neoplasia in situ. They have also studied lymphoid neoplasms of the urinary tract and male genital organs.

Clinical Focus:
Dr. Osunkoya's clinical focus is in Surgical Pathology with major emphasis on Urologic/Genitourinary Pathology. He signs out Urologic and General Surgical Pathology cases at both Emory University Hospital and the Veterans Affairs Medical Center. He also signs out gynecologic and non-gynecologic cytology (including urine cytology) cases at the latter. He handles in-house Urologic/Genitourinary Pathology consultation cases from Emory University Hospital, Veterans Affairs Medical Center, Emory Midtown Hospital, Grady Hospital and Children's Healthcare of Atlanta at Egleston and Scottish Rite. In addition, he offers expert consultation from outside institutions in the area of Urologic/Genitourinary Pathology (please see separate website link: https://med.emory.edu/departments/pathology/anatomic/expert-consult.html). He has a secondary appointment in the department of Urology.

Selected Awards/Honors/Prizes:
Benjamin Castleman Award, United States and Canadian Academy of Pathology (2010).
Arthur Purdy Stout Society of Surgical Pathologists Annual Prize (2015).

Selected National/International Service: President, United States and Canadian Academy of Pathology (2023-2024) https://uscap.org/past-presidents/

Academic Appointment

• Professor, Department of Urology, Emory University School of Medicine
• Professor, Department of Pathology & Laboratory Medicine, Emory University School of Medicine

Education

Research